FMC (FMC) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.61 per share. This compares to earnings of $1.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 11.18%. A quarter ago, it was expected that this chemical producer would post earnings of $0.49 per share when it actually produced earnings of $0.69, delivering a surprise of 40.82%.Over the last four quarters, the company has ...

Q4 2024 Earnings Presentation February 4, 2025 Q4 2024 Earnings Presentation FMC CORPORATION 1 Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements made in this presentation are forward- looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. In some cases, you can identify these forward-looking stat ...

Financial Data and Key Metrics Changes - Q4 revenue was $1,220 million, below guidance, but grew 7% year-over-year, with a 9% increase excluding divested sales from the Global Specialty Solutions business [22] - Full year 2024 sales declined 5%, while EBITDA decreased 8%, but EBITDA margin remained stable at 21% [25] - For 2025, full year sales are expected to be between $4,150 million and $4,350 million, flat at the midpoint compared to the prior year, with adjusted EPS projected between $3.26 and $3.70 [27][29] Business Line Data and Key Metrics Changes - Sales from the growth portfolio accounted for over 75% of the revenue growth in Q4, with the plant health business growing 33% [22] - The company anticipates branded sales to continue growing in 2025, but overall sales of Ronaxapyr are expected to decline due to cost-plus contracts and market repositioning [13][14] - The core portfolio is expected to grow at or slightly above market rates, while the growth portfolio is projected to grow significantly above market rates [19][75] Market Data and Key Metrics Changes - The company reported elevated channel inventories in several regions, including Latin America and Asia, impacting sales and pricing strategies [23][24] - The distribution channel in Brazil has undergone consolidation, affecting sales performance and prompting the exploration of new market routes [18] - The market for diamides is expected to grow from $2 billion to an estimated $5 billion over time, with FMC's branded diamides holding a significant market share [51][53] Company Strategy and Development Direction - The company is focusing on a diamide growth strategy, emphasizing the need to lower channel inventory and implement cost reduction measures [9][10] - FMC plans to invest in the sales organization to support new active ingredients and explore new routes to market, particularly in Latin America and EMEA [16][18] - The company aims to achieve substantial growth in 2026 and 2027, driven by new product introductions and a balanced core and growth portfolio [19][75] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the need for aggressive actions to reposition the company and improve market visibility, especially in light of evolving distribution channels [8][9] - The company expects a challenging first quarter in 2025 due to high channel inventories and cautious purchasing behavior from customers [30][31] - Management expressed confidence in the growth potential of new active ingredients and the overall strategy to drive commercialization of innovative products [19][76] Other Important Information - The restructuring program has exceeded savings targets, delivering $165 million in net savings for 2024, with expectations for over $250 million in run rate savings by the end of 2025 [36][41] - Free cash flow for 2024 was $614 million, a significant increase from the previous year, but is expected to decrease to between $200 million and $400 million in 2025 [42][44] - The effective tax rate for adjusted earnings was lower than expected at 10.9% for 2024, with a projected range of 13% to 15% for 2025 [39] Q&A Session All Questions and Answers Question: How does the company expect RenaxaPure to evolve from 2026 and beyond? - Management believes they can compete with generics at current pricing levels and will focus on expanding market reach while also developing high-end formulations to differentiate from generics [79][80][82] Question: Can you clarify the volume guidance for 2025? - Management explained that the increase in volume growth expectations is due to a strategic decision to lower channel inventory, which will drive more sales directly to the market rather than through the channel [85][86]

Exhibit 99.1 FMC Corporation 2929 Walnut Street Philadelphia, PA 19104 USA News Release 215.299.6000 For Release: Immediate fmc.com Media contact: Nicole Canning +1.215.299.5916 Nicole.Canning@fmc.com Investor contact: Curt Brooks +1.215.299.5899 Curt.Brooks@fmc.com FMC Corporation announces 2024 fourth quarter and full year results, provides 2025 outlook Fourth quarter results benefited from 7 percent sales growth and continued cost favorability; Company reported strong year of cash generation with over $1 ...

Fourth quarter results benefited from 7 percent sales growth and continued cost favorability; Company reported a strong year of cash generation with over $1 billion improvement in Cash from OperationsFourth Quarter 2024 Highlights Revenue of $1.22 billion, an increase of 7 percent versus Q4 2023 and up 12 percent organically1 Consolidated GAAP net loss of $16 million, down 101 percent versus Q4 2023 Adjusted EBITDA of $339 million, up 33 percent versus prior year, $3 million higher than guidance midpoint Co ...

FMC Corporation (FMC) is set to release fourth-quarter 2024 results after the closing bell on Feb. 4.See the Zacks Earnings Calendar to stay ahead of market-making news.The company beat the Zacks Consensus Estimate for earnings in three of the last four quarters and missed once. On average, FMC has a trailing four-quarter earnings surprise of around 17%. The company reported an earnings surprise of 40.8% in the last reported quarter.FMC is likely to have faced challenges from de-stocking and unabsorbed fixe ...

NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FMC Corporation (NYSE: FMC) on behalf of long-term stockholders following a class action complaint that was filed against FMC on November 9, 2023 with a Class Period from February 9, 2022 to October 30, 2023. Our investigation concerns whether the board of directors of FMC have breached their fiduciary duties to the company. On September 7, 2 ...

The market expects FMC (FMC) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on February 4, 2025, might help the stock move higher if these key numbers are bette ...

PHILADELPHIA, Jan. 23, 2025 /PRNewswire/ --  FMC Corporation (NYSE: FMC) announced today that its 2025 annual meeting of stockholders will be held via live webcast on Tuesday, April 29, 2025, at 2:00 p.m. ET. Instructions for accessing the webcast will be available on the company's Investor Relations website, located at https://investors.fmc.com. About FMC FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world populati ...

Market Sentiment and Options Activity - The June 6, 2025 $30 Call for FMC Corporation (FMC) has shown some of the highest implied volatility among all equity options recently, indicating potential significant price movement [1] - High implied volatility suggests that investors anticipate a substantial move in FMC's stock price, possibly due to an upcoming event that could trigger a rally or sell-off [2] Analyst Perspectives and Earnings Estimates - FMC Corporation holds a Zacks Rank 4 (Sell) in the Agriculture – Operations industry, which ranks in the Bottom 40% of the Zacks Industry Rank [3] - Over the past 60 days, one analyst has raised earnings estimates for the current quarter, while none have lowered them, resulting in a slight decrease in the Zacks Consensus Estimate from $1.67 to $1.65 per share [3] Trading Strategy and Implied Volatility - The high implied volatility in FMC's options may indicate a developing trade opportunity, with options traders potentially looking to sell premium to capture decay [4] - Seasoned traders often use this strategy, hoping that the underlying stock does not move as much as initially expected by expiration [4]